LEADER 01002nam--2200325---450- 001 990006170010203316 005 20160923104620.0 035 $a000617001 035 $aUSA01000617001 035 $a(ALEPH)000617001USA01 035 $a000617001 100 $a20160923d1966----km-y0itay50------ba 101 $aeng 102 $aBE 105 $a||||||||001yy 200 1 $aHumanistic and Renaissance studies in review$fby Sesto Prete 210 $aNew York$cFordham University press$d1966 215 $ap. 452-462$d24 cm 300 $aEstr. da: Traditio: studies in ancient and medieval history, thought and religion, v. 22., 1966 606 0 $aUmanesimo$xStudi$2BNCF 676 $a940.21 700 1$aPRETE,$bSesto$0155708 801 0$aIT$bsalbc$gISBD 912 $a990006170010203316 951 $aXV.3.Misc. 116$cXV.3.$d388193 959 $aBK 969 $aPAP 979 $aGIUSY$b90$c20160923$lUSA01$h1046 996 $aHumanistic and Renaissance studies in review$91393701 997 $aUNISA LEADER 01171nam 2200361 450 001 9910704420403321 005 20220602125922.0 035 $a(CKB)5470000002441494 035 $a(OCoLC)841163190 035 $a(EXLCZ)995470000002441494 100 $a20130429d2012 ua 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aAsian women-owned businesses 210 1$aWashington, DC :$cNational Women's Business Council,$d2012. 215 $a1 online resource (1 sheet) 300 $aTitle from title screen (viewed on Apr. 29, 2013). 606 $aWomen-owned business enterprises$zUnited States 606 $aAsian American business enterprises$zUnited States 606 $aAsian American women$zUnited States 615 0$aWomen-owned business enterprises 615 0$aAsian American business enterprises 615 0$aAsian American women 712 02$aNational Women's Business Council (U.S.), 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910704420403321 996 $aAsian women-owned businesses$93293989 997 $aUNINA LEADER 02852oas 2201093 a 450 001 9910144569503321 005 20251105213014.0 011 $a1557-8852 035 $a(DE-599)ZDB2520571-7 035 $a(OCoLC)45694108 035 $a(CONSER) 2005212454 035 $a(CKB)954925607868 035 $a(EXLCZ)99954925607868 100 $a20010110a19969999 sy a 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCancer biotherapy & radiopharmaceuticals 210 $aNew Rochelle, NY $cMary Ann Liebert, Inc 300 $aRefereed/Peer-reviewed 311 08$a1084-9785 517 3 $aCancer biotherapy and radiopharmaceuticals 606 $aCancer$xTreatment$vPeriodicals 606 $aRadiopharmaceuticals$vPeriodicals 606 $aBiological products$xTherapeutics$vPeriodicals 606 $aBiological Factors$xtherapeutic use 606 $aNeoplasms$xtherapy 606 $aRadioisotopes$xtherapeutic use 606 $aBiological Products$xtherapeutic use 606 $aCancer$xTraitement$vPe?riodiques 606 $aRadiopharmaceutiques$vPe?riodiques 606 $aCancer$xTreatment$2fast$3(OCoLC)fst00845538 606 $aRadiopharmaceuticals$2fast$3(OCoLC)fst01088327 608 $aPeriodical. 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 615 0$aCancer$xTreatment 615 0$aRadiopharmaceuticals 615 0$aBiological products$xTherapeutics 615 2$aBiological Factors$xtherapeutic use. 615 2$aNeoplasms$xtherapy 615 2$aRadioisotopes$xtherapeutic use. 615 2$aBiological Products$xtherapeutic use. 615 6$aCancer$xTraitement 615 6$aRadiopharmaceutiques 615 7$aCancer$xTreatment. 615 7$aRadiopharmaceuticals. 676 $a616 801 0$bF#A 801 1$bF#A 801 2$bOCLCQ 801 2$bOCLCS 801 2$bNSD 801 2$bOCLCQ 801 2$bMXC 801 2$bLGG 801 2$bPFM 801 2$bGBT 801 2$bOCLCQ 801 2$bFJM 801 2$bOCLCQ 801 2$bSERSO 801 2$bOCLCO 801 2$bDLC 801 2$bSERSO 801 2$bEUW 801 2$bOCLCQ 801 2$bU3W 801 2$bOCLCO 801 2$bOCLCF 801 2$bOCLCO 801 2$bMOW 801 2$bAU@ 801 2$bOCLCO 801 2$bWYU 801 2$bOCLCO 801 2$bUKMGB 801 2$bOCLCO 801 2$bOCLCA 801 2$bUHL 801 2$bOCLCQ 801 2$bOCLCO 801 2$bOCLCQ 801 2$bIOY 801 2$bOCLCL 801 2$bSFB 801 2$bSRU 801 2$bOCLCQ 906 $aJOURNAL 912 $a9910144569503321 996 $aCancer biotherapy & radiopharmaceuticals$92088307 997 $aUNINA